HomeBOIRF • OTCMKTS
Boiron SA
$28.50
Dec 18, 12:18:23 AM GMT-5 · USD · OTCMKTS · Disclaimer
StockUS listed security
Previous close
$28.50
Year range
$28.50 - $46.22
Market cap
473.73M EUR
Avg Volume
34.00
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Jun 2024Y/Y change
Revenue
114.17M-4.81%
Operating expense
77.02M-4.80%
Net income
1.67M-78.46%
Net profit margin
1.46-77.36%
Earnings per share
EBITDA
11.37M-3.88%
Effective tax rate
25.19%
Total assets
Total liabilities
(EUR)Jun 2024Y/Y change
Cash and short-term investments
53.33M-77.04%
Total assets
557.65M-25.92%
Total liabilities
184.68M-8.91%
Total equity
372.97M
Shares outstanding
17.36M
Price to book
1.33
Return on assets
3.06%
Return on capital
4.40%
Net change in cash
(EUR)Jun 2024Y/Y change
Net income
1.67M-78.46%
Cash from operations
6.77M-17.50%
Cash from investing
-5.09M24.82%
Cash from financing
-13.23M-36.19%
Net change in cash
-11.36M-22.93%
Free cash flow
5.75M-7.44%
About
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
Founded
Jun 7, 1932
Website
Employees
2,788
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu